nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—migraine—Prednisone—atopic dermatitis	0.559	1	CpDpCtD
Dihydroergotamine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0336	0.122	CbGbCtD
Dihydroergotamine—ABCB1—Tacrolimus—atopic dermatitis	0.0333	0.121	CbGbCtD
Dihydroergotamine—ABCB1—Loratadine—atopic dermatitis	0.0244	0.0888	CbGbCtD
Dihydroergotamine—ABCB1—Methylprednisolone—atopic dermatitis	0.0223	0.0813	CbGbCtD
Dihydroergotamine—CYP3A4—Tacrolimus—atopic dermatitis	0.02	0.0727	CbGbCtD
Dihydroergotamine—CYP3A4—Loratadine—atopic dermatitis	0.0146	0.0532	CbGbCtD
Dihydroergotamine—ABCB1—Betamethasone—atopic dermatitis	0.0145	0.0528	CbGbCtD
Dihydroergotamine—ABCB1—Prednisolone—atopic dermatitis	0.0143	0.0521	CbGbCtD
Dihydroergotamine—ABCB1—Hydrocortisone—atopic dermatitis	0.0136	0.0494	CbGbCtD
Dihydroergotamine—ABCB1—Prednisone—atopic dermatitis	0.0135	0.0492	CbGbCtD
Dihydroergotamine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0134	0.0487	CbGbCtD
Dihydroergotamine—CYP3A4—Triamcinolone—atopic dermatitis	0.0101	0.0369	CbGbCtD
Dihydroergotamine—CYP3A4—Betamethasone—atopic dermatitis	0.00869	0.0317	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisolone—atopic dermatitis	0.00858	0.0312	CbGbCtD
Dihydroergotamine—ABCB1—Dexamethasone—atopic dermatitis	0.00844	0.0307	CbGbCtD
Dihydroergotamine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00813	0.0296	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisone—atopic dermatitis	0.0081	0.0295	CbGbCtD
Dihydroergotamine—CYP3A4—Dexamethasone—atopic dermatitis	0.00506	0.0184	CbGbCtD
Dihydroergotamine—Myocardial infarction—Betamethasone—atopic dermatitis	0.000145	0.001	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000145	0.001	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000144	0.000996	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Betamethasone—atopic dermatitis	0.000144	0.000996	CcSEcCtD
Dihydroergotamine—Vomiting—Mometasone—atopic dermatitis	0.000142	0.000979	CcSEcCtD
Dihydroergotamine—Sweating increased—Prednisone—atopic dermatitis	0.000141	0.000975	CcSEcCtD
Dihydroergotamine—Visual impairment—Methylprednisolone—atopic dermatitis	0.000141	0.000975	CcSEcCtD
Dihydroergotamine—Urticaria—Tacrolimus—atopic dermatitis	0.000141	0.000974	CcSEcCtD
Dihydroergotamine—Rash—Mometasone—atopic dermatitis	0.000141	0.000971	CcSEcCtD
Dihydroergotamine—Dermatitis—Mometasone—atopic dermatitis	0.00014	0.00097	CcSEcCtD
Dihydroergotamine—Abdominal pain—Tacrolimus—atopic dermatitis	0.00014	0.000969	CcSEcCtD
Dihydroergotamine—Body temperature increased—Tacrolimus—atopic dermatitis	0.00014	0.000969	CcSEcCtD
Dihydroergotamine—Headache—Mometasone—atopic dermatitis	0.00014	0.000965	CcSEcCtD
Dihydroergotamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000139	0.000958	CcSEcCtD
Dihydroergotamine—Nausea—Mometasone—atopic dermatitis	0.000132	0.000915	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000131	0.000903	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000129	0.00089	CcSEcCtD
Dihydroergotamine—Visual impairment—Dexamethasone—atopic dermatitis	0.000128	0.000886	CcSEcCtD
Dihydroergotamine—Visual impairment—Betamethasone—atopic dermatitis	0.000128	0.000886	CcSEcCtD
Dihydroergotamine—Asthenia—Tacrolimus—atopic dermatitis	0.000127	0.00088	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000127	0.00088	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Prednisone—atopic dermatitis	0.000127	0.000875	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000126	0.000869	CcSEcCtD
Dihydroergotamine—Pruritus—Tacrolimus—atopic dermatitis	0.000126	0.000867	CcSEcCtD
Dihydroergotamine—Malaise—Prednisolone—atopic dermatitis	0.000125	0.000865	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisolone—atopic dermatitis	0.000125	0.000862	CcSEcCtD
Dihydroergotamine—Malaise—Hydrocortisone—atopic dermatitis	0.000122	0.000845	CcSEcCtD
Dihydroergotamine—Vertigo—Hydrocortisone—atopic dermatitis	0.000122	0.000842	CcSEcCtD
Dihydroergotamine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000121	0.000839	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisolone—atopic dermatitis	0.00012	0.000828	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000119	0.000819	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000118	0.000817	CcSEcCtD
Dihydroergotamine—Dizziness—Tacrolimus—atopic dermatitis	0.000117	0.000811	CcSEcCtD
Dihydroergotamine—Hypertension—Hydrocortisone—atopic dermatitis	0.000117	0.000809	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisolone—atopic dermatitis	0.000117	0.000807	CcSEcCtD
Dihydroergotamine—Myalgia—Hydrocortisone—atopic dermatitis	0.000115	0.000798	CcSEcCtD
Dihydroergotamine—Malaise—Triamcinolone—atopic dermatitis	0.000115	0.000796	CcSEcCtD
Dihydroergotamine—Anxiety—Hydrocortisone—atopic dermatitis	0.000115	0.000795	CcSEcCtD
Dihydroergotamine—Malaise—Methylprednisolone—atopic dermatitis	0.000115	0.000794	CcSEcCtD
Dihydroergotamine—Vertigo—Triamcinolone—atopic dermatitis	0.000115	0.000793	CcSEcCtD
Dihydroergotamine—Vertigo—Methylprednisolone—atopic dermatitis	0.000115	0.000791	CcSEcCtD
Dihydroergotamine—Discomfort—Hydrocortisone—atopic dermatitis	0.000114	0.000788	CcSEcCtD
Dihydroergotamine—Oedema—Prednisolone—atopic dermatitis	0.000113	0.000783	CcSEcCtD
Dihydroergotamine—Vomiting—Tacrolimus—atopic dermatitis	0.000113	0.00078	CcSEcCtD
Dihydroergotamine—Rash—Tacrolimus—atopic dermatitis	0.000112	0.000773	CcSEcCtD
Dihydroergotamine—Dermatitis—Tacrolimus—atopic dermatitis	0.000112	0.000772	CcSEcCtD
Dihydroergotamine—Shock—Prednisolone—atopic dermatitis	0.000112	0.00077	CcSEcCtD
Dihydroergotamine—Headache—Tacrolimus—atopic dermatitis	0.000111	0.000768	CcSEcCtD
Dihydroergotamine—Oedema—Hydrocortisone—atopic dermatitis	0.000111	0.000765	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisolone—atopic dermatitis	0.000111	0.000764	CcSEcCtD
Dihydroergotamine—Hypertension—Triamcinolone—atopic dermatitis	0.00011	0.000762	CcSEcCtD
Dihydroergotamine—Hypertension—Methylprednisolone—atopic dermatitis	0.00011	0.00076	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00011	0.000757	CcSEcCtD
Dihydroergotamine—Shock—Hydrocortisone—atopic dermatitis	0.000109	0.000752	CcSEcCtD
Dihydroergotamine—Myalgia—Triamcinolone—atopic dermatitis	0.000109	0.000751	CcSEcCtD
Dihydroergotamine—Myalgia—Methylprednisolone—atopic dermatitis	0.000109	0.00075	CcSEcCtD
Dihydroergotamine—Arthralgia—Methylprednisolone—atopic dermatitis	0.000109	0.00075	CcSEcCtD
Dihydroergotamine—Anxiety—Methylprednisolone—atopic dermatitis	0.000108	0.000747	CcSEcCtD
Dihydroergotamine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000108	0.000746	CcSEcCtD
Dihydroergotamine—Flushing—Prednisone—atopic dermatitis	0.000108	0.000743	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000108	0.000743	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000108	0.000743	CcSEcCtD
Dihydroergotamine—Discomfort—Triamcinolone—atopic dermatitis	0.000107	0.000742	CcSEcCtD
Dihydroergotamine—Discomfort—Methylprednisolone—atopic dermatitis	0.000107	0.000741	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000107	0.000739	CcSEcCtD
Dihydroergotamine—Dry mouth—Triamcinolone—atopic dermatitis	0.000106	0.000735	CcSEcCtD
Dihydroergotamine—Anorexia—Hydrocortisone—atopic dermatitis	0.000106	0.000729	CcSEcCtD
Dihydroergotamine—Nausea—Tacrolimus—atopic dermatitis	0.000105	0.000728	CcSEcCtD
Dihydroergotamine—Confusional state—Methylprednisolone—atopic dermatitis	0.000105	0.000725	CcSEcCtD
Dihydroergotamine—Malaise—Dexamethasone—atopic dermatitis	0.000105	0.000722	CcSEcCtD
Dihydroergotamine—Malaise—Betamethasone—atopic dermatitis	0.000105	0.000722	CcSEcCtD
Dihydroergotamine—Oedema—Triamcinolone—atopic dermatitis	0.000104	0.00072	CcSEcCtD
Dihydroergotamine—Vertigo—Dexamethasone—atopic dermatitis	0.000104	0.000719	CcSEcCtD
Dihydroergotamine—Vertigo—Betamethasone—atopic dermatitis	0.000104	0.000719	CcSEcCtD
Dihydroergotamine—Hypotension—Hydrocortisone—atopic dermatitis	0.000103	0.000715	CcSEcCtD
Dihydroergotamine—Shock—Triamcinolone—atopic dermatitis	0.000103	0.000709	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisolone—atopic dermatitis	0.000103	0.000708	CcSEcCtD
Dihydroergotamine—Shock—Methylprednisolone—atopic dermatitis	0.000102	0.000707	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisolone—atopic dermatitis	0.000102	0.000703	CcSEcCtD
Dihydroergotamine—Tachycardia—Triamcinolone—atopic dermatitis	0.000102	0.000703	CcSEcCtD
Dihydroergotamine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000102	0.000701	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000101	0.000697	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000101	0.000696	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000101	0.000695	CcSEcCtD
Dihydroergotamine—Insomnia—Hydrocortisone—atopic dermatitis	0.0001	0.000692	CcSEcCtD
Dihydroergotamine—Hypertension—Dexamethasone—atopic dermatitis	0.0001	0.000691	CcSEcCtD
Dihydroergotamine—Hypertension—Betamethasone—atopic dermatitis	0.0001	0.000691	CcSEcCtD
Dihydroergotamine—Paraesthesia—Hydrocortisone—atopic dermatitis	9.94e-05	0.000687	CcSEcCtD
Dihydroergotamine—Myalgia—Betamethasone—atopic dermatitis	9.87e-05	0.000682	CcSEcCtD
Dihydroergotamine—Myalgia—Dexamethasone—atopic dermatitis	9.87e-05	0.000682	CcSEcCtD
Dihydroergotamine—Anxiety—Dexamethasone—atopic dermatitis	9.83e-05	0.000679	CcSEcCtD
Dihydroergotamine—Anxiety—Betamethasone—atopic dermatitis	9.83e-05	0.000679	CcSEcCtD
Dihydroergotamine—Discomfort—Dexamethasone—atopic dermatitis	9.75e-05	0.000673	CcSEcCtD
Dihydroergotamine—Discomfort—Betamethasone—atopic dermatitis	9.75e-05	0.000673	CcSEcCtD
Dihydroergotamine—Dyspepsia—Hydrocortisone—atopic dermatitis	9.75e-05	0.000673	CcSEcCtD
Dihydroergotamine—Hypotension—Methylprednisolone—atopic dermatitis	9.72e-05	0.000671	CcSEcCtD
Dihydroergotamine—Pain—Prednisolone—atopic dermatitis	9.69e-05	0.00067	CcSEcCtD
Dihydroergotamine—Decreased appetite—Hydrocortisone—atopic dermatitis	9.62e-05	0.000665	CcSEcCtD
Dihydroergotamine—Fatigue—Hydrocortisone—atopic dermatitis	9.55e-05	0.000659	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	9.5e-05	0.000656	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.48e-05	0.000655	CcSEcCtD
Dihydroergotamine—Pain—Hydrocortisone—atopic dermatitis	9.47e-05	0.000654	CcSEcCtD
Dihydroergotamine—Oedema—Betamethasone—atopic dermatitis	9.46e-05	0.000653	CcSEcCtD
Dihydroergotamine—Oedema—Dexamethasone—atopic dermatitis	9.46e-05	0.000653	CcSEcCtD
Dihydroergotamine—Insomnia—Triamcinolone—atopic dermatitis	9.43e-05	0.000651	CcSEcCtD
Dihydroergotamine—Insomnia—Methylprednisolone—atopic dermatitis	9.41e-05	0.00065	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisone—atopic dermatitis	9.37e-05	0.000647	CcSEcCtD
Dihydroergotamine—Paraesthesia—Triamcinolone—atopic dermatitis	9.36e-05	0.000647	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisolone—atopic dermatitis	9.34e-05	0.000645	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methylprednisolone—atopic dermatitis	9.34e-05	0.000645	CcSEcCtD
Dihydroergotamine—Shock—Betamethasone—atopic dermatitis	9.31e-05	0.000643	CcSEcCtD
Dihydroergotamine—Shock—Dexamethasone—atopic dermatitis	9.31e-05	0.000643	CcSEcCtD
Dihydroergotamine—Dyspnoea—Triamcinolone—atopic dermatitis	9.29e-05	0.000642	CcSEcCtD
Dihydroergotamine—Agitation—Prednisone—atopic dermatitis	9.28e-05	0.000641	CcSEcCtD
Dihydroergotamine—Tachycardia—Dexamethasone—atopic dermatitis	9.23e-05	0.000638	CcSEcCtD
Dihydroergotamine—Tachycardia—Betamethasone—atopic dermatitis	9.23e-05	0.000638	CcSEcCtD
Dihydroergotamine—Dyspepsia—Triamcinolone—atopic dermatitis	9.18e-05	0.000634	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methylprednisolone—atopic dermatitis	9.16e-05	0.000633	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.14e-05	0.000632	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Betamethasone—atopic dermatitis	9.14e-05	0.000632	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.12e-05	0.00063	CcSEcCtD
Dihydroergotamine—Malaise—Prednisone—atopic dermatitis	9.1e-05	0.000629	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisone—atopic dermatitis	9.07e-05	0.000626	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.05e-05	0.000625	CcSEcCtD
Dihydroergotamine—Anorexia—Dexamethasone—atopic dermatitis	9.02e-05	0.000623	CcSEcCtD
Dihydroergotamine—Anorexia—Betamethasone—atopic dermatitis	9.02e-05	0.000623	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisolone—atopic dermatitis	9.01e-05	0.000622	CcSEcCtD
Dihydroergotamine—Fatigue—Triamcinolone—atopic dermatitis	8.99e-05	0.000621	CcSEcCtD
Dihydroergotamine—Fatigue—Methylprednisolone—atopic dermatitis	8.97e-05	0.00062	CcSEcCtD
Dihydroergotamine—Pain—Triamcinolone—atopic dermatitis	8.92e-05	0.000616	CcSEcCtD
Dihydroergotamine—Hypotension—Dexamethasone—atopic dermatitis	8.84e-05	0.000611	CcSEcCtD
Dihydroergotamine—Hypotension—Betamethasone—atopic dermatitis	8.84e-05	0.000611	CcSEcCtD
Dihydroergotamine—Urticaria—Hydrocortisone—atopic dermatitis	8.8e-05	0.000608	CcSEcCtD
Dihydroergotamine—Body temperature increased—Hydrocortisone—atopic dermatitis	8.75e-05	0.000605	CcSEcCtD
Dihydroergotamine—Abdominal pain—Hydrocortisone—atopic dermatitis	8.75e-05	0.000605	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisone—atopic dermatitis	8.71e-05	0.000602	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	8.62e-05	0.000595	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	8.62e-05	0.000595	CcSEcCtD
Dihydroergotamine—Arthralgia—Prednisone—atopic dermatitis	8.59e-05	0.000594	CcSEcCtD
Dihydroergotamine—Myalgia—Prednisone—atopic dermatitis	8.59e-05	0.000594	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Triamcinolone—atopic dermatitis	8.59e-05	0.000593	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.57e-05	0.000592	CcSEcCtD
Dihydroergotamine—Anxiety—Prednisone—atopic dermatitis	8.56e-05	0.000592	CcSEcCtD
Dihydroergotamine—Insomnia—Betamethasone—atopic dermatitis	8.56e-05	0.000591	CcSEcCtD
Dihydroergotamine—Insomnia—Dexamethasone—atopic dermatitis	8.56e-05	0.000591	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.51e-05	0.000588	CcSEcCtD
Dihydroergotamine—Paraesthesia—Dexamethasone—atopic dermatitis	8.49e-05	0.000587	CcSEcCtD
Dihydroergotamine—Paraesthesia—Betamethasone—atopic dermatitis	8.49e-05	0.000587	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisone—atopic dermatitis	8.49e-05	0.000586	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisolone—atopic dermatitis	8.35e-05	0.000577	CcSEcCtD
Dihydroergotamine—Dyspepsia—Betamethasone—atopic dermatitis	8.33e-05	0.000575	CcSEcCtD
Dihydroergotamine—Dyspepsia—Dexamethasone—atopic dermatitis	8.33e-05	0.000575	CcSEcCtD
Dihydroergotamine—Urticaria—Triamcinolone—atopic dermatitis	8.28e-05	0.000572	CcSEcCtD
Dihydroergotamine—Urticaria—Methylprednisolone—atopic dermatitis	8.26e-05	0.000571	CcSEcCtD
Dihydroergotamine—Body temperature increased—Triamcinolone—atopic dermatitis	8.24e-05	0.000569	CcSEcCtD
Dihydroergotamine—Oedema—Prednisone—atopic dermatitis	8.24e-05	0.000569	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methylprednisolone—atopic dermatitis	8.22e-05	0.000568	CcSEcCtD
Dihydroergotamine—Decreased appetite—Betamethasone—atopic dermatitis	8.22e-05	0.000568	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dexamethasone—atopic dermatitis	8.22e-05	0.000568	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.16e-05	0.000563	CcSEcCtD
Dihydroergotamine—Fatigue—Betamethasone—atopic dermatitis	8.16e-05	0.000563	CcSEcCtD
Dihydroergotamine—Fatigue—Dexamethasone—atopic dermatitis	8.16e-05	0.000563	CcSEcCtD
Dihydroergotamine—Shock—Prednisone—atopic dermatitis	8.1e-05	0.00056	CcSEcCtD
Dihydroergotamine—Pain—Dexamethasone—atopic dermatitis	8.09e-05	0.000559	CcSEcCtD
Dihydroergotamine—Pain—Betamethasone—atopic dermatitis	8.09e-05	0.000559	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisone—atopic dermatitis	8.04e-05	0.000555	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisone—atopic dermatitis	7.96e-05	0.00055	CcSEcCtD
Dihydroergotamine—Asthenia—Hydrocortisone—atopic dermatitis	7.94e-05	0.000549	CcSEcCtD
Dihydroergotamine—Anorexia—Prednisone—atopic dermatitis	7.85e-05	0.000542	CcSEcCtD
Dihydroergotamine—Pruritus—Hydrocortisone—atopic dermatitis	7.83e-05	0.000541	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betamethasone—atopic dermatitis	7.8e-05	0.000538	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dexamethasone—atopic dermatitis	7.8e-05	0.000538	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.74e-05	0.000534	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.74e-05	0.000534	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Triamcinolone—atopic dermatitis	7.68e-05	0.000531	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.66e-05	0.000529	CcSEcCtD
Dihydroergotamine—Diarrhoea—Hydrocortisone—atopic dermatitis	7.58e-05	0.000523	CcSEcCtD
Dihydroergotamine—Urticaria—Dexamethasone—atopic dermatitis	7.51e-05	0.000519	CcSEcCtD
Dihydroergotamine—Urticaria—Betamethasone—atopic dermatitis	7.51e-05	0.000519	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.51e-05	0.000518	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisolone—atopic dermatitis	7.5e-05	0.000518	CcSEcCtD
Dihydroergotamine—Asthenia—Triamcinolone—atopic dermatitis	7.48e-05	0.000517	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dexamethasone—atopic dermatitis	7.48e-05	0.000517	CcSEcCtD
Dihydroergotamine—Abdominal pain—Betamethasone—atopic dermatitis	7.48e-05	0.000517	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dexamethasone—atopic dermatitis	7.48e-05	0.000517	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betamethasone—atopic dermatitis	7.48e-05	0.000517	CcSEcCtD
Dihydroergotamine—Asthenia—Methylprednisolone—atopic dermatitis	7.46e-05	0.000516	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisone—atopic dermatitis	7.45e-05	0.000515	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisone—atopic dermatitis	7.4e-05	0.000511	CcSEcCtD
Dihydroergotamine—Pruritus—Triamcinolone—atopic dermatitis	7.38e-05	0.00051	CcSEcCtD
Dihydroergotamine—Pruritus—Methylprednisolone—atopic dermatitis	7.36e-05	0.000508	CcSEcCtD
Dihydroergotamine—Dizziness—Hydrocortisone—atopic dermatitis	7.32e-05	0.000506	CcSEcCtD
Dihydroergotamine—Dyspepsia—Prednisone—atopic dermatitis	7.25e-05	0.000501	CcSEcCtD
Dihydroergotamine—Decreased appetite—Prednisone—atopic dermatitis	7.16e-05	0.000495	CcSEcCtD
Dihydroergotamine—Rash—Prednisolone—atopic dermatitis	7.15e-05	0.000494	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisolone—atopic dermatitis	7.14e-05	0.000493	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methylprednisolone—atopic dermatitis	7.12e-05	0.000492	CcSEcCtD
Dihydroergotamine—Fatigue—Prednisone—atopic dermatitis	7.1e-05	0.000491	CcSEcCtD
Dihydroergotamine—Headache—Prednisolone—atopic dermatitis	7.1e-05	0.000491	CcSEcCtD
Dihydroergotamine—Vomiting—Hydrocortisone—atopic dermatitis	7.04e-05	0.000486	CcSEcCtD
Dihydroergotamine—Rash—Hydrocortisone—atopic dermatitis	6.98e-05	0.000482	CcSEcCtD
Dihydroergotamine—Dermatitis—Hydrocortisone—atopic dermatitis	6.97e-05	0.000482	CcSEcCtD
Dihydroergotamine—Headache—Hydrocortisone—atopic dermatitis	6.94e-05	0.000479	CcSEcCtD
Dihydroergotamine—Dizziness—Triamcinolone—atopic dermatitis	6.89e-05	0.000476	CcSEcCtD
Dihydroergotamine—Dizziness—Methylprednisolone—atopic dermatitis	6.88e-05	0.000475	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisone—atopic dermatitis	6.79e-05	0.000469	CcSEcCtD
Dihydroergotamine—Asthenia—Dexamethasone—atopic dermatitis	6.79e-05	0.000469	CcSEcCtD
Dihydroergotamine—Asthenia—Betamethasone—atopic dermatitis	6.79e-05	0.000469	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Prednisone—atopic dermatitis	6.74e-05	0.000465	CcSEcCtD
Dihydroergotamine—Nausea—Prednisolone—atopic dermatitis	6.73e-05	0.000465	CcSEcCtD
Dihydroergotamine—Pruritus—Dexamethasone—atopic dermatitis	6.69e-05	0.000462	CcSEcCtD
Dihydroergotamine—Pruritus—Betamethasone—atopic dermatitis	6.69e-05	0.000462	CcSEcCtD
Dihydroergotamine—Vomiting—Triamcinolone—atopic dermatitis	6.63e-05	0.000458	CcSEcCtD
Dihydroergotamine—Vomiting—Methylprednisolone—atopic dermatitis	6.61e-05	0.000457	CcSEcCtD
Dihydroergotamine—Nausea—Hydrocortisone—atopic dermatitis	6.58e-05	0.000454	CcSEcCtD
Dihydroergotamine—Rash—Triamcinolone—atopic dermatitis	6.57e-05	0.000454	CcSEcCtD
Dihydroergotamine—Dermatitis—Triamcinolone—atopic dermatitis	6.57e-05	0.000454	CcSEcCtD
Dihydroergotamine—Rash—Methylprednisolone—atopic dermatitis	6.56e-05	0.000453	CcSEcCtD
Dihydroergotamine—Dermatitis—Methylprednisolone—atopic dermatitis	6.55e-05	0.000453	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisone—atopic dermatitis	6.54e-05	0.000452	CcSEcCtD
Dihydroergotamine—Headache—Triamcinolone—atopic dermatitis	6.53e-05	0.000451	CcSEcCtD
Dihydroergotamine—Headache—Methylprednisolone—atopic dermatitis	6.52e-05	0.00045	CcSEcCtD
Dihydroergotamine—Abdominal pain—Prednisone—atopic dermatitis	6.51e-05	0.00045	CcSEcCtD
Dihydroergotamine—Body temperature increased—Prednisone—atopic dermatitis	6.51e-05	0.00045	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dexamethasone—atopic dermatitis	6.47e-05	0.000447	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betamethasone—atopic dermatitis	6.47e-05	0.000447	CcSEcCtD
Dihydroergotamine—Dizziness—Betamethasone—atopic dermatitis	6.26e-05	0.000432	CcSEcCtD
Dihydroergotamine—Dizziness—Dexamethasone—atopic dermatitis	6.26e-05	0.000432	CcSEcCtD
Dihydroergotamine—Nausea—Triamcinolone—atopic dermatitis	6.19e-05	0.000428	CcSEcCtD
Dihydroergotamine—Nausea—Methylprednisolone—atopic dermatitis	6.18e-05	0.000427	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisone—atopic dermatitis	6.07e-05	0.000419	CcSEcCtD
Dihydroergotamine—Vomiting—Dexamethasone—atopic dermatitis	6.01e-05	0.000415	CcSEcCtD
Dihydroergotamine—Vomiting—Betamethasone—atopic dermatitis	6.01e-05	0.000415	CcSEcCtD
Dihydroergotamine—Rash—Betamethasone—atopic dermatitis	5.96e-05	0.000412	CcSEcCtD
Dihydroergotamine—Rash—Dexamethasone—atopic dermatitis	5.96e-05	0.000412	CcSEcCtD
Dihydroergotamine—Dermatitis—Dexamethasone—atopic dermatitis	5.96e-05	0.000412	CcSEcCtD
Dihydroergotamine—Dermatitis—Betamethasone—atopic dermatitis	5.96e-05	0.000412	CcSEcCtD
Dihydroergotamine—Headache—Betamethasone—atopic dermatitis	5.93e-05	0.000409	CcSEcCtD
Dihydroergotamine—Headache—Dexamethasone—atopic dermatitis	5.93e-05	0.000409	CcSEcCtD
Dihydroergotamine—Asthenia—Prednisone—atopic dermatitis	5.91e-05	0.000408	CcSEcCtD
Dihydroergotamine—Pruritus—Prednisone—atopic dermatitis	5.83e-05	0.000403	CcSEcCtD
Dihydroergotamine—Diarrhoea—Prednisone—atopic dermatitis	5.64e-05	0.000389	CcSEcCtD
Dihydroergotamine—Nausea—Dexamethasone—atopic dermatitis	5.62e-05	0.000388	CcSEcCtD
Dihydroergotamine—Nausea—Betamethasone—atopic dermatitis	5.62e-05	0.000388	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisone—atopic dermatitis	5.45e-05	0.000376	CcSEcCtD
Dihydroergotamine—Vomiting—Prednisone—atopic dermatitis	5.24e-05	0.000362	CcSEcCtD
Dihydroergotamine—Rash—Prednisone—atopic dermatitis	5.19e-05	0.000359	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisone—atopic dermatitis	5.19e-05	0.000358	CcSEcCtD
Dihydroergotamine—Headache—Prednisone—atopic dermatitis	5.16e-05	0.000356	CcSEcCtD
Dihydroergotamine—Nausea—Prednisone—atopic dermatitis	4.89e-05	0.000338	CcSEcCtD
Dihydroergotamine—ADRA2A—Hemostasis—IL5—atopic dermatitis	2.82e-05	0.00131	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—IL5—atopic dermatitis	2.79e-05	0.0013	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	2.79e-05	0.0013	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL5—atopic dermatitis	2.78e-05	0.00129	CbGpPWpGaD
Dihydroergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.76e-05	0.00128	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	2.76e-05	0.00128	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCL17—atopic dermatitis	2.75e-05	0.00128	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.74e-05	0.00127	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	2.73e-05	0.00127	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—TAC1—atopic dermatitis	2.73e-05	0.00127	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—NPS—atopic dermatitis	2.73e-05	0.00127	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	2.7e-05	0.00125	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—KIF3A—atopic dermatitis	2.69e-05	0.00125	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CXCL10—atopic dermatitis	2.69e-05	0.00125	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CXCR3—atopic dermatitis	2.68e-05	0.00124	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	2.67e-05	0.00124	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	2.65e-05	0.00123	CbGpPWpGaD
Dihydroergotamine—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.65e-05	0.00123	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	2.61e-05	0.00121	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CXCL10—atopic dermatitis	2.61e-05	0.00121	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.6e-05	0.0012	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	2.59e-05	0.0012	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.56e-05	0.00119	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL5—atopic dermatitis	2.54e-05	0.00118	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	2.54e-05	0.00118	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	2.49e-05	0.00115	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	2.48e-05	0.00115	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—KIF3A—atopic dermatitis	2.45e-05	0.00114	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	2.44e-05	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	2.44e-05	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CMA1—atopic dermatitis	2.43e-05	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCL11—atopic dermatitis	2.43e-05	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	2.41e-05	0.00112	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	2.41e-05	0.00112	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.4e-05	0.00111	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCL11—atopic dermatitis	2.39e-05	0.00111	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	2.39e-05	0.00111	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CXCL10—atopic dermatitis	2.38e-05	0.00111	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.38e-05	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CXCL10—atopic dermatitis	2.37e-05	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	2.36e-05	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	2.36e-05	0.0011	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—FCER2—atopic dermatitis	2.36e-05	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	2.35e-05	0.00109	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CCL5—atopic dermatitis	2.31e-05	0.00107	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	2.3e-05	0.00107	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—STAT6—atopic dermatitis	2.29e-05	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	2.27e-05	0.00105	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	2.27e-05	0.00105	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CCL5—atopic dermatitis	2.25e-05	0.00104	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	2.23e-05	0.00104	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—GLB1—atopic dermatitis	2.23e-05	0.00104	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	2.23e-05	0.00103	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	2.22e-05	0.00103	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CMA1—atopic dermatitis	2.22e-05	0.00103	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCL11—atopic dermatitis	2.22e-05	0.00103	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	2.21e-05	0.00103	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	2.21e-05	0.00103	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.21e-05	0.00102	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL22—atopic dermatitis	2.19e-05	0.00102	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	2.18e-05	0.00101	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	2.17e-05	0.00101	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—CXCL8—atopic dermatitis	2.17e-05	0.001	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CXCL10—atopic dermatitis	2.16e-05	0.001	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CCR3—atopic dermatitis	2.15e-05	0.000997	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	2.15e-05	0.000997	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.15e-05	0.000996	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ADSL—atopic dermatitis	2.14e-05	0.000993	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.11e-05	0.000976	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	2.1e-05	0.000976	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	2.09e-05	0.000969	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—STAT6—atopic dermatitis	2.09e-05	0.000968	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	2.08e-05	0.000967	CbGpPWpGaD
Dihydroergotamine—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.08e-05	0.000965	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.06e-05	0.000957	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	2.06e-05	0.000954	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CCL5—atopic dermatitis	2.05e-05	0.000951	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CCL5—atopic dermatitis	2.04e-05	0.000946	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	2.02e-05	0.000939	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CCR5—atopic dermatitis	2.02e-05	0.000939	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	2.01e-05	0.000932	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	1.99e-05	0.000923	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	1.98e-05	0.00092	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCR3—atopic dermatitis	1.98e-05	0.000919	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—CXCL8—atopic dermatitis	1.98e-05	0.000917	CbGpPWpGaD
Dihydroergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.97e-05	0.000913	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	1.97e-05	0.000912	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	1.97e-05	0.000912	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	1.96e-05	0.000907	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	1.95e-05	0.000905	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.93e-05	0.000896	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	1.93e-05	0.000893	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	1.92e-05	0.000889	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	1.92e-05	0.000889	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.88e-05	0.000871	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CCL5—atopic dermatitis	1.86e-05	0.000864	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CCR5—atopic dermatitis	1.85e-05	0.000857	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CCR5—atopic dermatitis	1.84e-05	0.000853	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	1.82e-05	0.000846	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCR3—atopic dermatitis	1.81e-05	0.000839	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	1.8e-05	0.000835	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	1.8e-05	0.000835	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	1.79e-05	0.000828	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	1.78e-05	0.000826	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TAC1—atopic dermatitis	1.77e-05	0.000819	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NPS—atopic dermatitis	1.77e-05	0.000819	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	1.75e-05	0.000814	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	1.75e-05	0.000814	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	1.75e-05	0.000813	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NPS—atopic dermatitis	1.75e-05	0.000813	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	1.74e-05	0.000807	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	1.74e-05	0.000807	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCR3—atopic dermatitis	1.73e-05	0.000803	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	1.72e-05	0.000797	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	1.72e-05	0.000796	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NPS—atopic dermatitis	1.72e-05	0.000796	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	1.71e-05	0.000791	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	1.69e-05	0.000785	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	1.68e-05	0.000781	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CCR5—atopic dermatitis	1.68e-05	0.000778	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	1.66e-05	0.000771	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.65e-05	0.000767	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL5—atopic dermatitis	1.64e-05	0.000762	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL5—atopic dermatitis	1.63e-05	0.000756	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	1.62e-05	0.00075	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TAC1—atopic dermatitis	1.61e-05	0.000748	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NPS—atopic dermatitis	1.61e-05	0.000748	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	1.6e-05	0.000744	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL5—atopic dermatitis	1.6e-05	0.00074	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCR3—atopic dermatitis	1.58e-05	0.000733	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	1.56e-05	0.000725	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GLB1—atopic dermatitis	1.54e-05	0.000716	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.52e-05	0.000704	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	1.51e-05	0.000701	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL5—atopic dermatitis	1.5e-05	0.000695	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	1.5e-05	0.000695	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.49e-05	0.000693	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ADSL—atopic dermatitis	1.48e-05	0.000686	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	1.47e-05	0.00068	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	1.41e-05	0.000656	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	1.41e-05	0.000656	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCL10—atopic dermatitis	1.4e-05	0.000649	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	1.39e-05	0.000645	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	1.38e-05	0.00064	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	1.36e-05	0.000631	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	1.36e-05	0.000631	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	1.33e-05	0.000617	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.31e-05	0.000606	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.31e-05	0.000606	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	1.31e-05	0.000606	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.28e-05	0.000595	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	1.28e-05	0.000593	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.26e-05	0.000584	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CXCL8—atopic dermatitis	1.22e-05	0.000568	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.22e-05	0.000564	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.21e-05	0.000563	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCL5—atopic dermatitis	1.21e-05	0.000559	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.2e-05	0.000555	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.19e-05	0.000552	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.19e-05	0.000551	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.18e-05	0.000548	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.18e-05	0.000546	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.17e-05	0.000543	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	1.17e-05	0.000542	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1.16e-05	0.000538	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.15e-05	0.000535	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.14e-05	0.000527	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.12e-05	0.000518	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NGF—atopic dermatitis	1.12e-05	0.000518	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	1.11e-05	0.000515	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.11e-05	0.000514	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.1e-05	0.000512	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.1e-05	0.00051	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCR5—atopic dermatitis	1.09e-05	0.000504	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.08e-05	0.000503	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.08e-05	0.000501	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.08e-05	0.0005	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.08e-05	0.000499	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.07e-05	0.000496	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.07e-05	0.000496	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	1.07e-05	0.000495	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL2—atopic dermatitis	1.06e-05	0.000493	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.06e-05	0.000489	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.05e-05	0.000489	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.04e-05	0.000481	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.03e-05	0.000479	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.03e-05	0.000477	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.03e-05	0.000477	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	1.02e-05	0.000473	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.01e-05	0.000471	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.01e-05	0.000467	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	9.91e-06	0.00046	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	9.69e-06	0.00045	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	9.55e-06	0.000443	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GLB1—atopic dermatitis	9.51e-06	0.000441	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	9.21e-06	0.000427	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	9.14e-06	0.000424	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ADSL—atopic dermatitis	9.12e-06	0.000423	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	9.06e-06	0.00042	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	8.95e-06	0.000415	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	8.92e-06	0.000414	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	8.66e-06	0.000402	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	8.4e-06	0.00039	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NGF—atopic dermatitis	8.26e-06	0.000383	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	8.23e-06	0.000382	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	8.15e-06	0.000378	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	8.04e-06	0.000373	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	7.86e-06	0.000365	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PPARA—atopic dermatitis	7.24e-06	0.000336	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.12e-06	0.00033	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	7.01e-06	0.000325	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	6.81e-06	0.000316	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	6.8e-06	0.000316	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	6.57e-06	0.000305	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	6.52e-06	0.000302	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	6.49e-06	0.000301	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	6.47e-06	0.0003	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	6.38e-06	0.000296	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	6.32e-06	0.000293	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL2—atopic dermatitis	6.27e-06	0.000291	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL6—atopic dermatitis	6.24e-06	0.00029	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL2—atopic dermatitis	6.23e-06	0.000289	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	6.2e-06	0.000287	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	6.18e-06	0.000287	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL2—atopic dermatitis	6.1e-06	0.000283	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	6.07e-06	0.000281	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	5.99e-06	0.000278	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	5.78e-06	0.000268	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	5.73e-06	0.000266	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	5.73e-06	0.000266	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	5.7e-06	0.000264	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	5.61e-06	0.00026	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.36e-06	0.000248	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	5.27e-06	0.000245	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPARA—atopic dermatitis	5.01e-06	0.000232	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	4.86e-06	0.000225	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL2—atopic dermatitis	4.64e-06	0.000215	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	4.62e-06	0.000214	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	4.27e-06	0.000198	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.82e-06	0.000177	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL6—atopic dermatitis	3.69e-06	0.000171	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL6—atopic dermatitis	3.66e-06	0.00017	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	3.65e-06	0.000169	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	3.63e-06	0.000168	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL6—atopic dermatitis	3.58e-06	0.000166	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.37e-06	0.000156	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	3.36e-06	0.000156	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.09e-06	0.000143	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.73e-06	0.000127	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	2.15e-06	9.95e-05	CbGpPWpGaD
